Literature DB >> 11489289

Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease.

H Hanyu1, T Asano, H Sakurai, M Takasaki, H Shindo, K Abe.   

Abstract

We measured magnetization transfer ratios (MTRs) of the hippocampus in 38 patients with Alzheimer's disease (AD), including very mild (Clinical Dementia Rating [CDR] 0.5, n=12), mild (CDR 1, n=14), and moderate stages (CDR 2, n=12), and in 21 healthy elderly control subjects. Medial temporal lobe atrophy was graded subjectively on a five-point scale by two observers blinded to clinical data. Compared with the controls, each of the AD groups, including the very mild group, had significant atrophy of the medial temporal lobe and a decrease in MTRs of the hippocampus. Logistic regression analysis revealed that the overall discrimination rate with MTR measurement and visual analysis of the atrophy was 85% and 73% between the control group and the CDR 0.5 group, 89% and 80% between the control group and the CDR 1 group, and 100% and 91% between the control group and the CDR 2 group, respectively. MTR measurements may provide additional information in detecting structural damage of the hippocampus of AD and be helpful in providing improved diagnosis and early detection of AD.

Entities:  

Mesh:

Year:  2001        PMID: 11489289     DOI: 10.1016/s0022-510x(01)00553-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

Review 1.  Advancing imaging technologies for patients with spinal pain: with a focus on whiplash injury.

Authors:  James M Elliott; Mark J Hancock; Rebecca J Crawford; Andrew C Smith; David M Walton
Journal:  Spine J       Date:  2017-07-31       Impact factor: 4.166

2.  Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment.

Authors:  M Mascalchi; A Ginestroni; V Bessi; N Toschi; S Padiglioni; S Ciulli; C Tessa; M Giannelli; L Bracco; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

3.  Visual rating versus volumetry to detect frontotemporal dementia.

Authors:  T W Chow; F Gao; K A Links; J E Ween; D F Tang-Wai; J Ramirez; C J M Scott; M Freedman; D T Stuss; S E Black
Journal:  Dement Geriatr Cogn Disord       Date:  2011-05-31       Impact factor: 2.959

4.  Comprehensive brain analysis with automated high-resolution magnetization transfer measurements.

Authors:  Ying Wu; Hongyan Du; Pippa Storey; Christopher Glielmi; Fiona Malone; Shawn Sidharthan; Ann Ragin; Paul S Tofts; Robert R Edelman
Journal:  J Magn Reson Imaging       Date:  2011-10-11       Impact factor: 4.813

5.  Longitudinal magnetization transfer imaging in mild to severe Alzheimer disease.

Authors:  S Ropele; R Schmidt; C Enzinger; M Windisch; N P Martinez; F Fazekas
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

6.  Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging.

Authors:  A C G M van Es; W M van der Flier; F Admiraal-Behloul; H Olofsen; E L E M Bollen; H A M Middelkoop; A W E Weverling-Rijnsburger; J van der Grond; R G J Westendorp; M A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

7.  Subcortical biophysical abnormalities in patients with mood disorders.

Authors:  A Kumar; S Yang; O Ajilore; M Wu; R Charlton; M Lamar
Journal:  Mol Psychiatry       Date:  2013-07-23       Impact factor: 15.992

Review 8.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 9.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01

Review 10.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.